Published in Clinical Oncology Week, January 22nd, 2007
"Patients with stage IIIB or IV chemotherapy-na´ve NSCLC with EGFR mutation were treated with 250 mg gefitinib...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.